Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction—The case of VHL (von Hippel‐Lindau) protein and angiogenesis regulatory pathway

Using the tumor suppressor VHL protein as an example, we show that detailed analysis of conservation versus variation pattern in the multiple alignment can be coupled with the genomic pathway/complex conservation analysis to provide a more complete picture of the entire interaction/regulatory network. Results from the present study have allowed us to hypothesize that two additional proteins are involved in the VHL‐mediated regulation of angiogenesis. Detailed modeling also has led to a prediction of the possible interaction mode between the known and the proposed parts of the VHL complex. To aid in an analysis of the VHL protein regulation of HIF‐1α degradation, an important and only partially understood process that directly influences angiogenesis, we performed a comprehensive search for the orthologs of the VHL as well as for VHL‐interacting proteins in all the available eukaryotic genomes. Analysis of a multiple alignment of thus identified VHL orthologs reveals an unusually high degree of conservation of the surface amino acid residues that almost exactly correspond to positions mutated in the VHL disease‐associated tumors. In addition, these positions form well‐defined clusters in three‐dimensional space, and presence or absence of individual clusters correlates with the presence or absence of pathway elements in different genomes. We have also shown that relation trees derived from the multiple sequence alignment, functional surface‐mapping, and HIF‐1α degradation pathway structure are in complete agreement, linking the functional and structural evolution of the VHL protein and VHL‐dependent HIF‐1α degradation complex.

[1]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[2]  J. Widom,et al.  Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.

[3]  D. Eisenberg,et al.  Detecting protein function and protein-protein interactions from genome sequences. , 1999, Science.

[4]  W. Kaelin,et al.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.

[5]  M. Ivan,et al.  The von Hippel-Lindau tumor suppressor protein. , 2001, Current opinion in genetics & development.

[6]  Christophe Béroud,et al.  Software and database for the analysis of mutations in the VHL gene , 1998, Nucleic Acids Res..

[7]  O. Lichtarge Evolutionarily conserved Gaypy binding surfaces support amodel oftheG protein-receptor complex , 1996 .

[8]  W. Kaelin,et al.  The VHL tumour-suppressor gene paradigm. , 1998, Trends in genetics : TIG.

[9]  K. Davies,et al.  Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism , 2002, Nature Cell Biology.

[10]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[11]  Paramvir S. Dehal,et al.  Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes , 2002, Science.

[12]  D. Church,et al.  Cross-species sequence comparisons: a review of methods and available resources. , 2003, Genome research.

[13]  R. Klausner,et al.  Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Ratcliffe,et al.  The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. , 2001, Advances in experimental medicine and biology.

[15]  D. Morrison Phylogenetic tree-building. , 1996, International journal for parasitology.

[16]  W. Kaelin,et al.  Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2 , 1998, Molecular and Cellular Biology.

[17]  A. Kibel,et al.  Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C , 1995, Science.

[18]  W. S. Valdar,et al.  Scoring residue conservation , 2002, Proteins.

[19]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[20]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[21]  William Arbuthnot Sir Lane,et al.  Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II , 1995, Science.

[22]  M. Nei,et al.  Phylogenetic analysis in molecular evolutionary genetics. , 1996, Annual review of genetics.

[23]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[24]  Fugu: a compact vertebrate reference genome , 2000, FEBS letters.

[25]  F. Cohen,et al.  An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.

[26]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F E Cohen,et al.  Identification of functional surfaces of the zinc binding domains of intracellular receptors. , 1997, Journal of molecular biology.